                         SEQUENCE LISTING

<110>  F. Hoffmann - La Roche AG
 
<120>  PHARMACODYNAMIC BIOMARKERS FOR PERSONALIZED CANCER CARE USING 
       EPIGENETIC MODIFYING AGENTS

<130>  P33920-WO

<150>  EP 16197012.4
<151>  2016-11-03

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  1
gtcaacgccg tagatgacc                                                    19


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  2
ttgttagccc cgttcttcag                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  3
ggagcttctc gacttcacca                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  4
ctaaagatgc aggttgtgcg                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  5
ctggagaaac ctgccaagta                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  6
tgttgctgta gccgtattca                                                   20


